Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Marketable Securities | 8 | 10 | 60 | 120 | 270 |
| Receivables | 50 | 10 | 80 | 10 | 40 |
| Inventories | N/A | N/A | N/A | 6 | 10 |
| Other current assets | 2 | 10 | 10 | 14 | 0 |
| TOTAL | $60 | $30 | $150 | $150 | $320 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $10 | $10 | $10 | $10 | $10 |
| Total Assets | $100 | $70 | $250 | $310 | $530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accrued Expenses | N/A | N/A | N/A | 6 | 6 |
| TOTAL | $400 | $670 | $430 | $170 | $240 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| TOTAL | $1,500 | $1,500 | $1,500 | $1,500 | $1,500 |
| Total Liabilities | $1,900 | $2,170 | $1,930 | $1,670 | $1,740 |
| Shareholders' Equity | |||||
| Common Shares | 180 | 130 | 120 | 120 | 110 |
| Retained earnings | -20,310 | -19,800 | -19,260 | -18,560 | -17,770 |
| Other shareholders' equity | 10 | 0 | 20 | 20 | 20 |
| TOTAL | $-2,280 | $-2,560 | $-2,110 | $-1,770 | $-1,720 |
| Total Liabilities And Equity | $-380 | $-390 | $-180 | $-100 | $20 |